Physician profile
Carson Wong
NPI 1669440814
$3,216.18
in general payments reported to CMS, 2019-2025
19 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.37 · 2020: $13.69 · 2021: $92.87 · 2022: $324 · 2023: $1,672 · 2024: $350 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,069 · Travel and Lodging: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,069.03 |
| Travel and Lodging | $630.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,240.80 | 2023 | Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $493.10 | 2023-2025 | Orgovyx |
| Becton, Dickinson and Company | $450.67 | 2023-2025 | Bard Urinary Drainage Bag, Aptra, Arista Ah Flexitip |
| C. R. Bard, INC. & Subsidiaries | $421.37 | 2019-2025 | Bard Urinary Drainage Bag, Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Dornier Medtech America, INC | $134.38 | 2022 | |
| Intuitive Surgical, INC. | $94.63 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $94.29 | 2019-2025 | Xtandi |
| Myovant Sciences INC. | $55.10 | 2021-2022 | |
| Axonics, INC. | $30.09 | 2022 | |
| Telix Pharmaceuticals | $28.81 | 2025 | Illuccix |
| Janssen Biotech, INC. | $28.34 | 2019 | |
| Conmed Corporation | $25.67 | 2024 | Airseal |
| Progenics Pharmaceuticals, INC. | $23.52 | 2023 | Pylarify |
| Pacira Pharmaceuticals Incorporated | $17.45 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.73 | 2025 | Adstiladrin |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.71 | 2023 | Bridion |
| Baxter Healthcare | $16.20 | 2022 | |
| Pfizer INC. | $14.63 | 2019 | |
| Coloplast Corp | $13.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.